Skip to main content
Advertisement

< Back to Article

Fig 1.

Maltalep trial: Flow chart of leprosy incidence and lost to follow-up.

More »

Fig 1 Expand

Fig 2.

Non-intervention cohort: Flow chart of leprosy incidence and lost to follow-up.

More »

Fig 2 Expand

Table 1.

Leprosy incidence per 10,000 Population in contacts of new leprosy patients: Maltalep trial (N = 14,547) and non-intervention cohort (N = 4,216).

More »

Table 1 Expand

Fig 3.

Leprosy incidence per 10,000 population.

More »

Fig 3 Expand

Table 2.

Characteristics at intake of contacts of index leprosy patients (Maltalep trial, N = 14,986) by treatment allocation, and the non-intervention cohort (N = 4,216).

More »

Table 2 Expand

Table 3.

Cluster unadjusted bi-variate association of risk factors and leprosy incidence.

More »

Table 3 Expand

Table 4.

Results of multivariable and multilevel mixed-effects logistic regression analysis, Maltalep trial after SDR was given, N = 14,547.

More »

Table 4 Expand

Table 5.

Results of multilevel mixed-effects logistic regression analysis, Maltalep trial and non-intervention cohort.

More »

Table 5 Expand